IMARC Group, a leading market research company, has recently released a report titled "EPA & DHA Market Report by Type (Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA)), Source (Fish Oil, Algae Oil, Krill Oil, and Others), Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Others), and Region 2025-2033." The study provides a detailed analysis of the industry, including the global EPA & DHA market size, share, trends, growth and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

MARKET OVERVIEW

The global EPA & DHA market reached a size of USD 1,990.5 Million in 2024. It is projected to grow to USD 3,369.6 Million by 2033, exhibiting a CAGR of 5.72% during 2025-2033. This growth is driven by increased consumer awareness of omega-3 fatty acids' health benefits, rising demand for functional foods and supplements, and sustainable sourcing practices in the fishing industry.

STUDY ASSUMPTION YEARS

  • Base Year: 2024
  • Historical Years: 2019-2024
  • Forecast Period: 2025-2033

EPA & DHA MARKET KEY TAKEAWAYS

  • Current Market Size: USD 1,990.5 Million (2024)
  • CAGR: 5.72% (2025-2033)
  • Forecast Period: 2025-2033
  • Docosahexaenoic Acid (DHA) is the largest type segment in the market.
  • Fish oil is the largest source segment for EPA & DHA.
  • Dietary supplements represent the largest application segment.
  • Asia Pacific is the dominant geographical region, driven by factors like a growing geriatric population and awareness of health and fitness.

Claim Your Free “EPA & DHA Market” Insights Sample PDF: https://www.imarcgroup.com/epa-dha-market/requestsample

MARKET GROWTH FACTORS

The EPA & DHA market rapidly grows due to consumers increasingly becoming aware of the health benefits from omega-3 fatty acids and due to people using EPA and DHA for preventing chronic diseases like cardiovascular disease, diabetes, and cancer. Favorable government regulations exist as extra growth drivers, and demand increases for functional foods plus dietary supplements with EPA & DHA exists, especially among the geriatric population.

The growth of technologies to produce high-purity and high-concentration EPA and DHA supplements and functional food products enables manufacturers to meet increasing market demand with effective high-quality docosahexaenoic acid (DHA) and EPA containing dietary products. Growth in vegan dietary habits has also increased interest in the ingestion of plant-based EPA and DHA sources, such as algae-based dietary supplements.

The factors supporting the market growth include regulatory changes, labeling requirement changes, and suppliers' need to innovate and update their product portfolio and strategies accordingly. Other factors supporting the growth of the market are the increasing rate of urbanization, implementation of sustainable and green fishing practices, increasing disposable incomes, and meaningful R&D activities.

MARKET SEGMENTATION

Type Insights:

  • Eicosapentaenoic Acid (EPA): Long-chain polyunsaturated omega-3 fatty acid essential for human health, sourced typically from fish.
  • Docosahexaenoic Acid (DHA): Largest segment; important omega-3 fatty acid vital for brain function, widely found in fish and algae.

Source Insights:

  • Fish Oil: Largest segment; a primary and bioavailable source of EPA and DHA from fatty fish.
  • Algae Oil: A plant-based source, increasingly used due to rising vegan diet adoption.
  • Krill Oil: An alternative marine source of EPA and DHA.
  • Others:

Application Insights:

  • Infant Formulae: Use of EPA and DHA to support infant development.
  • Dietary Supplements: Largest application segment, driven by health and wellness trends.
  • Fortified Food and Beverages: Foods enhanced with EPA and DHA to provide additional health benefits.
  • Pharmaceuticals: Use in medicinal products for health enhancement.
  • Others:

REGIONAL INSIGHTS:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Asia Pacific is the largest market for EPA & DHA. This dominance is attributed to factors such as a growing geriatric population, continual technological advancements in sustainable fishing practices, and increased awareness related to health and fitness. These elements contribute significantly to the demand and expansion of the EPA & DHA market in this region.

KEY PLAYERS

  • AlgiSy BioSciences Inc.
  • Arctic Nutrition AG
  • BASF SE
  • Biosearch Sau
  • Corbion NV
  • Croda International PLC
  • KD Pharma Group
  • Koninklijke DSM NV
  • Nordic Naturals Inc
  • Novasep Holding SAS
  • Novotech Nutraceuticals Inc
  • Omega Protein Corporation
  • Polaris

Ask Analyst For Request Customization: https://www.imarcgroup.com/request?type=report&id=7339&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302